Fidelity Group of Funds > Fidelity Select Portfolios
Select Health Care Portfolio
$8.00B
Avg Monthly Net Assets
$7.39B
Total Assets
$89.97M
Total Liabilities
$7.30B
Net Assets
Select Health Care Portfolio is a Mutual Fund in Fidelity Select Portfolios
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has one share class
and monthly net assets of $8.00B.
On July 26th, 2024 it reported 98 holdings, the largest
being BOSTON SCIENTIFIC CORP (11.0%), UNITEDHEALTH GROUP INC (8.7%) and ELI LILLY and CO (8.5%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Select Health Care Portfolio | C000020440 | FSPHX |
Holdings
From latest NPORT-P, filed July 26th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC | Long | Equity-common | US | $44M | 2M | 0.61 |
| 10X GENOMICS INC CL B 144A | Long | Equity-common | US | $11M | 500K | 0.15 |
| ACADIA HEALTHCARE CO INC | Long | Equity-common | US | $3M | 41K | 0.04 |
| ACELYRIN INC | Long | Equity-common | US | $4M | 900K | 0.05 |
| ACUMEN PHARMACEUTICALS INC | Long | Equity-common | US | $3M | 1M | 0.05 |
| AGILON HEALTH INC | Long | Equity-common | US | $65M | 10M | 0.89 |
| ALEDADE INC SER B1 PC PP | Long | Equity-preferred | US | $8M | 201K | 0.11 |
| ALEDADE INC SER E1 PC PP | Long | Equity-preferred | US | $2M | 57K | 0.03 |
| ALIGNMENT HEALTHCARE INC | Long | Equity-common | US | $44M | 6M | 0.60 |
| ALLOGENE THERAPEUTICS INC | Long | Equity-common | US | $10M | 4M | 0.14 |
| ALNYLAM PHARMACEUTICALS INC | Long | Equity-common | US | $80M | 540K | 1.10 |
| APOGEE THERAPEUTICS INC | Long | Equity-common | US | $2M | 53K | 0.03 |
| ARCELLX INC | Long | Equity-common | US | $21M | 400K | 0.28 |
| ARCUS BIOSCIENCES INC | Long | Equity-common | US | $11M | 700K | 0.14 |
| ARGENX SE SPONSORED ADR | Long | Equity-common | NL | $104M | 280K | 1.42 |
| ASCENDIS PHARMA AS SPON ADR (ASCENDIS PHARMA A/S) | Long | Equity-common | DK | $111M | 820K | 1.52 |
| ASIMOV INC SER B PC PP | Long | Equity-preferred | US | $5M | 101K | 0.06 |
| ASTRAZENECA PLC | Long | Equity-common | GB | $124M | 800K | 1.70 |
| AVIDITY BIOSCIENCES (AVIDITY BIOSCIENCES INC) | Long | Equity-common | US | $27M | 1M | 0.37 |
| BLUEPRINT MEDICINES CORP | Long | Equity-common | US | $74M | 700K | 1.01 |
| BOSTON SCIENTIFIC CORP | Long | Equity-common | US | $805M | 11M | 11.02 |
| BRIGHTSPRING HEALTH SERVICES INC | Long | Equity-common | US | $32M | 3M | 0.44 |
| BRUKER CORP | Long | Equity-common | US | $62M | 940K | 0.84 |
| CARGO THERAPEUTICS INC | Long | Equity-common | US | $19M | 996K | 0.26 |
| CARIS LIFE SCIENCES INC PP | Long | Equity-common | US | $4M | 1M | 0.05 |
| CARIS LIFE SCIENCES INC SER D PC PP | Long | Equity-preferred | US | $8M | 3M | 0.11 |
| CELLDEX THERAPEUTICS INC | Long | Equity-common | US | $18M | 550K | 0.25 |
| CENTENE CORP (CENTENE CORP DEL) | Long | Equity-common | US | $143M | 2M | 1.96 |
| CIGNA GROUP (THE) | Long | Equity-common | US | $241M | 700K | 3.30 |
| CLEERLY INC SER C PC PP | Long | Equity-preferred | US | $14M | 1M | 0.19 |
| CVS HEALTH CORP | Long | Equity-common | US | $151M | 3M | 2.07 |
| CYTOKINETICS INC | Long | Equity-common | US | $72M | 1M | 0.98 |
| DANAHER CORP | Long | Equity-common | US | $488M | 2M | 6.68 |
| DMED BIOPHARMACEUTICAL CO LTD SER C PC PP | Long | Equity-preferred | CN | $2M | 380K | 0.02 |
| EDGEWISE THERAPEUTICS INC | Long | Equity-common | US | $10M | 560K | 0.13 |
| EDWARDS LIFESCIENCES CORP | Long | Equity-common | US | $109M | 1M | 1.49 |
| ELEMENT BIOSCIENCES INC SER C PC PP | Long | Equity-preferred | US | $5M | 572K | 0.07 |
| ELEVATEBIO LLC SER C PC PP (ELEVATEBIO, LLC) | Long | Equity-preferred | US | $780K | 255K | 0.01 |
| ELI LILLY and CO | Long | Equity-common | US | $623M | 760K | 8.54 |
| ENDEAVOR BIOMEDICINES INC SERIES C PC PP | Long | Equity-preferred | US | $9M | 1M | 0.12 |
| ENLIVEN THERAPEUTICS INC | Long | Equity-common | US | $11M | 500K | 0.15 |
| EVOLENT HEALTH INC A | Long | Equity-common | US | $32M | 2M | 0.44 |
| EXACT SCIENCES CORP | Long | Equity-common | US | $76M | 2M | 1.04 |
| Fidelity Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $37M | 37M | 0.51 |
| Fidelity Securities Lending Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $76M | 76M | 1.05 |
| GALVANIZE THERAPEUTICS CONV 6% 02/28/2027 P/P | Long | Debt | US | $3M | – | 0.05 |
| GALVANIZE THERAPEUTICS SER B PC PERP PP | Long | Equity-preferred | US | $3M | 4M | 0.04 |
| GLAUKOS CORP | Long | Equity-common | US | $113M | 1M | 1.54 |
| HEAL THRIVE HOLDINGS LLC PP | Long | Equity-common | US | $5M | 473K | 0.07 |
| IMMUNOCORE HOLDINGS LTD ADR (IMMUNOCORE HOLDINGS PLC) | Long | Equity-common | GB | $19M | 392K | 0.26 |
| INSCRIPTA INC SER E PC PP | Long | Equity-preferred | US | $4M | 1M | 0.05 |
| INSMED INC | Long | Equity-common | US | $30M | 550K | 0.41 |
| INSPIRE MEDICAL SYSTEMS INC | Long | Equity-common | US | $77M | 485K | 1.05 |
| INSULET CORP | Long | Equity-common | US | $124M | 700K | 1.70 |
| INTELLIA THERAPEUTICS INC | Long | Equity-common | US | $12M | 560K | 0.16 |
| INTUITIVE SURGICAL INC | Long | Equity-common | US | $123M | 305K | 1.68 |
| IQVIA HOLDINGS INC | Long | Equity-common | US | $81M | 370K | 1.11 |
| JANUX THERAPEUTICS INC | Long | Equity-common | US | $35M | 650K | 0.48 |
| KARDIUM INC CONV 10% 12/31/2026 PP (KARDIUM INC/CA) | Long | Debt | CA | $12M | – | 0.17 |
| KEROS THERAPEUTICS (KEROS THERAPEUTICS INC) | Long | Equity-common | US | $30M | 650K | 0.42 |
| LEGEND BIOTECH CORP SPON ADR | Long | Equity-common | KY | $100M | 3M | 1.37 |
| LIFESTANCE HEALTH GROUP INC | Long | Equity-common | US | $50M | 9M | 0.69 |
| LONZA GROUP AG | Long | Equity-common | CH | $36M | 67K | 0.50 |
| MASIMO CORP | Long | Equity-common | US | $106M | 850K | 1.45 |
| MEDICAL MICROINSTRUMENTS INC SER C PC PP | Long | Equity-preferred | US | $10M | 316K | 0.14 |
| MEDICAL MICROINSTRUMENTS INC WT 02/16/2031 PP | Long | Equity-common | US | $196K | 16K | 0.00 |
| MERCK and CO INC NEW | Long | Equity-common | US | $311M | 2M | 4.26 |
| MERUS B.V. (MERUS NV) | Long | Equity-common | NL | $34M | 640K | 0.47 |
| MOLINA HEALTHCARE INC | Long | Equity-common | US | $39M | 125K | 0.54 |
| MORPHIC HOLDING INC | Long | Equity-common | US | $14M | 450K | 0.19 |
| NUVALENT INC-A | Long | Equity-common | US | $44M | 670K | 0.60 |
| OMADA HEALTH INC SER E PC PP | Long | Equity-preferred | US | $9M | 2M | 0.12 |
| ORUKA THERAPEUTICS INC PIPE | Long | Equity-common | US | $9M | 1M | 0.12 |
| PENUMBRA INC | Long | Equity-common | US | $242M | 1M | 3.32 |
| PHARVARIS BV | Long | Equity-common | NL | $14M | 738K | 0.19 |
| PHREESIA INC | Long | Equity-common | US | $28M | 1M | 0.38 |
| POSEIDA THERAPEUTICS INC | Long | Equity-common | US | $7M | 2M | 0.10 |
| PRIVIA HEALTH GROUP INC | Long | Equity-common | US | $71M | 4M | 0.97 |
| PROCEPT BIOROBOTICS CORP | Long | Equity-common | US | $42M | 640K | 0.58 |
| REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $294M | 300K | 4.03 |
| REPLIGEN (REPLIGEN CORP) | Long | Equity-common | US | $18M | 120K | 0.25 |
| ROYALTY PHARMA PLC | Long | Equity-common | GB | $66M | 2M | 0.90 |
| SALUDA MEDICAL INC SER E PC PP | Long | Equity-preferred | US | $8M | 1M | 0.11 |
| SPYRE THERAPEUTICS INC | Long | Equity-common | US | $17M | 500K | 0.24 |
| STRUCTURE THERAPEUTICS INC ADR | Long | Equity-common | KY | $22M | 650K | 0.30 |
| STRYKER CORP | Long | Equity-common | US | $124M | 365K | 1.71 |
| SUMMIT THERAPEUTICS INC | Long | Equity-common | US | $10M | 1M | 0.13 |
| SURGERY PARTNERS INC | Long | Equity-common | US | $99M | 4M | 1.36 |
| THERMO FISHER SCIENTIFIC INC | Long | Equity-common | US | $118M | 208K | 1.62 |
| UCB SA | Long | Equity-common | BE | $70M | 500K | 0.96 |
| UNITEDHEALTH GROUP INC | Long | Equity-common | US | $634M | 1M | 8.68 |
| VAXCYTE INC | Long | Equity-common | US | $102M | 1M | 1.40 |
| VEEVA SYS INC CL A | Long | Equity-common | US | $84M | 480K | 1.15 |
| VIKING THERAPEUTICS INC | Long | Equity-common | US | $3M | 52K | 0.04 |
| VIRIDIAN THERAPEUTICS INC | Long | Equity-common | US | $18M | 2M | 0.25 |
| WUGEN INC SER B PC PP | Long | Equity-preferred | US | $2M | 454K | 0.02 |
| XENON PHARMACEUTICALS INC | Long | Equity-common | CA | $46M | 1M | 0.63 |
| ZENTALIS PHARMACEUTICALS LLC (ZENTALIS PHARMACEUTICALS INC) | Long | Equity-common | US | $11M | 900K | 0.15 |
Address
Fidelity Select Portfolios
245 Summer Street
Boston
Massachusetts
02210
United States of America
Directors
OSCAR MUNOZ
ROBERT A LAWRENCE
THOMAS A KENNEDY
BETTINA DOULTON
VICKI L FULLER
VIJAY ADVANI
THOMAS P BOSTICK
PATRICIA L KAMPLING
DONALD F DONAHUE
MICHAEL E WILEY
SUSAN TOMASKY
DAVID M THOMAS
Transfer Agents
Fidelity Investments Institutional Operations Company LLC
Pricing Services
REFINITIV US HOLDINGS INC
INTERCONTINENTAL EXCHANGE INC
Custodians
CITIBANK N.A. JAKARTA BRANCH
STANDARD CHARTERED BANK (SINGAPORE) LIMITED
STANDARD BANK OF SOUTH AFRICA LIMITED
BANK HAPOALIM BM
RBC INVESTOR SERVICES TRUST
DEUTSCHE BANK AG
HSBC BANK AUSTRALIA LIMITED
HSBC BANK PLC
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) DANMARK BRANCH
HSBC BANK PLC
CITIBANK KOREA INC
BNP PARIBAS S.A. SUCCURSALE ITALIA
CITIBANK ANONIM SIRKETI
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED NEW ZEALAND BRANCH
BNP PARIBAS S.A. ATHENS BRANCH
BNP PARIBAS S.A.
CITIBANK N.A.- MUMBAI BRANCH
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
BNP PARIBAS S.A.
STANDARD CHARTERED BANK (CHINA) LIMITED
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)
MUFG BANK LTD.
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED THAILAND BRANCH
DEUTSCHE BANK AG
BROWN BROTHERS HARRIMAN & CO.
CITIBANK N.A. SAO PAULO
CREDIT SUISSE (SWITZERLAND) LTD.
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) OSLO BRANCH
SOCIETE GENERALE SUCURSAL EN ESPANA
Shareholder Servicing Agents
Fidelity Investments Institutional Operations Company LLC
Admins
Fidelity Service Company
Brokers
B RILEY FINANCIAL INC
BARCLAYS PLC
CITIGROUP INC
MORGAN STANLEY
BANK OF AMERICA CORPORATION
JEFFERIES FINANCIAL GROUP INC
GOLDMAN SACHS GROUP INC (THE)
VIRTU FINANCIAL INC
JPMORGAN CHASE and CO
UBS GROUP AG